Trilogy Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5M Buy
12,033
+10,812
+886% +$4.01M 0.19% 88
2026
Q1
$330K Buy
1,221
+411
+51% +$122K 0.01% 309
2025
Q4
$267K Buy
810
+129
+19% +$43.7K 0.01% 332
2025
Q3
$235K Buy
+681
New +$206K 0.01% 352
2025
Q2
Sell
-695
Closed -$364K 378
2025
Q1
$364K Sell
695
-116
-14% -$59.3K 0.02% 256
2024
Q4
$410K Sell
811
-46
-5% -$26.1K 0.02% 246
2024
Q3
$501K Buy
857
+51
+6% +$28.8K 0.03% 223
2024
Q2
$411K Buy
806
+335
+71% +$164K 0.02% 231
2024
Q1
$233K Buy
+471
New +$239K 0.01% 274
2023
Q3
Sell
-506
Closed -$256K 272
2023
Q2
$256K Buy
506
+23
+5% +$11.2K 0.02% 246
2023
Q1
$228K Buy
483
+13
+3% +$6.27K 0.02% 235
2022
Q4
$249K Buy
+470
New +$249K 0.02% 231
2018
Q4
Sell
-126
Closed -$34K 534
2018
Q3
$34K Hold
126
﹤0.01% 225
2018
Q2
$31K Buy
126
+5
+4% +$1.2K ﹤0.01% 221
2018
Q1
$26K Buy
+121
New +$27.6K ﹤0.01% 208

Other funds holding UNH

Trilogy Capital's UNH Position: Q2 2026 in Review

Trilogy Capital increased its UnitedHealth (UNH) stake by 886% in Q2 2026, buying an estimated $4.01M and bringing the position to 12,033 shares worth $5M. The position accounts for 0.19% of the portfolio, ranked #88.

Trilogy Capital first reported a position in UNH in Q1 2018 and has held it in 15 quarters since. 1,855 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Trilogy Capital held 12,033 shares of UnitedHealth worth $5M as of Q2 2026.
  • Trilogy Capital bought 10,812 UnitedHealth shares in Q2 2026, an estimated $4.01M.
  • UnitedHealth made up 0.19% of Trilogy Capital's portfolio in Q2 2026, its #88 holding.
  • Trilogy Capital first reported a position in UnitedHealth in Q1 2018 and has held it in 15 quarters since.
  • 1,855 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.